3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
15
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
2
Cardiotoxicity
2
Urogenital Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Heart Diseases
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Breast Cancer Female
1
Brain Neoplasms
1
Interventions
liposomal doxorubicin
1
Vitamin D
1
Progestins
1
Mass Screening
1
Hormone Replacement Therapy
1
Exercise Test
1
Estrogens
1
Estrogen Replacement Therapy
1
Echocardiography
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Diagnosis
1
Calcium
1
Blood Specimen Collection
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Heart Diseases
×
Atorvastatin
×
Breast
×
Clear all
NCT02674204
2019-05-15
STOP
Cedars-Sinai Medical Center
Phase 2
Terminated
2 enrolled
7 charts